These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 15192827)
1. [Application of the Bgl II-Bln I dosage test to gene diagnosis of facioscapulohumeral muscular dystrophy 1A gene]. Su QX; Zhang C; Xie YM; Zeng Y; Liu XR; Lu XL; Zhu YZ Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):245-7. PubMed ID: 15192827 [TBL] [Abstract][Full Text] [Related]
2. [Translocation between chromosomes 4q35 and 10q26 in facioscapulohumeral muscular dystrophy]. Su QX; Zhang C; Zeng Y; Lu XL; Liu XR; Wang ZH; Zhu YZ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):581-4. PubMed ID: 14650163 [TBL] [Abstract][Full Text] [Related]
3. A new dosage test for subtelomeric 4;10 translocations improves conventional diagnosis of facioscapulohumeral muscular dystrophy (FSHD). van der Maarel SM; Deidda G; Lemmers RJ; Bakker E; van der Wielen MJ; Sandkuijl L; Hewitt JE; Padberg GW; Frants RR J Med Genet; 1999 Nov; 36(11):823-8. PubMed ID: 10544225 [TBL] [Abstract][Full Text] [Related]
4. [Gene diagnosis of facioscapulohumeral muscular dystrophy]. Zhang JL; Shen DG; Zhou PK; Liu JW; Jia N; Liu H; Wang HB; Yang SX; Frants RR Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):232-4. PubMed ID: 12778451 [TBL] [Abstract][Full Text] [Related]
5. [Mechanism of translocation between chromosomes 4q and 10q in facioscapulohumeral muscular dystrophy]. Wang N; Wu ZY; Wang CD; Wang ZQ; Lin MT; Fang L; Murong SX Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(8):650-3. PubMed ID: 12887821 [TBL] [Abstract][Full Text] [Related]
6. [Gene diagnosis of facioscapulohumeral muscular dystrophy]. Zeng Y; Zhang C; Su Q Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):213-5. PubMed ID: 11402453 [TBL] [Abstract][Full Text] [Related]
7. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes]. Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016 [TBL] [Abstract][Full Text] [Related]
8. [Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy]. Su Q; Zhang C Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):398-401. PubMed ID: 11592052 [TBL] [Abstract][Full Text] [Related]
9. Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues. Tsien F; Sun B; Hopkins NE; Vedanarayanan V; Figlewicz D; Winokur S; Ehrlich M Mol Genet Metab; 2001 Nov; 74(3):322-31. PubMed ID: 11708861 [TBL] [Abstract][Full Text] [Related]
10. Prenatal diagnosis for facioscapulohumeral muscular dystrophy (FSHD). Upadhyaya M; MacDonald M; Ravine D Prenat Diagn; 1999 Oct; 19(10):959-65. PubMed ID: 10521823 [TBL] [Abstract][Full Text] [Related]
11. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion. Krasnianski M; Eger K; Neudecker S; Jakubiczka S; Zierz S Arch Neurol; 2003 Oct; 60(10):1421-5. PubMed ID: 14568813 [TBL] [Abstract][Full Text] [Related]
12. Molecular diagnosis of facioscapulohumeral muscular dystrophy. Upadhyaya M; Cooper DN Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336 [TBL] [Abstract][Full Text] [Related]
13. [Facioscapulohumeral muscular dystrophy (FSHD)]. Funakoshi M; Goto K; Kim BY; Arahata K Nihon Rinsho; 1997 Dec; 55(12):3181-5. PubMed ID: 9436432 [TBL] [Abstract][Full Text] [Related]
14. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132 [TBL] [Abstract][Full Text] [Related]
15. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338 [TBL] [Abstract][Full Text] [Related]
16. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion. Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic challenges in facioscapulohumeral muscular dystrophy. Sacconi S; Salviati L; Bourget I; Figarella D; Péréon Y; Lemmers R; van der Maarel S; Desnuelle C Neurology; 2006 Oct; 67(8):1464-6. PubMed ID: 17060574 [TBL] [Abstract][Full Text] [Related]
19. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy. Goto K; Nishino I; Hayashi YK Neuromuscul Disord; 2006 Apr; 16(4):256-61. PubMed ID: 16545566 [TBL] [Abstract][Full Text] [Related]
20. [Study on EcoR I fragment polymorphism of the subtelomeric domains within 4q35 and 10q26 with pulsed field gel electrophoresis in the Chinese population]. Wu ZY; Wang ZQ; Wang N; Lin MT; Murong SX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):552-6. PubMed ID: 15583980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]